Delivery Order SPE2D020D0009-SPE2D324F287J

Award Date 9/24/24
Potential Completion Date 9/27/24
Potential Value $27K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lake Zurich, IL, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract is for the delivery of DOXYCYCLINE HYDROCHLORIDE INJECTION (10), a critical care medication, to military medical facilities worldwide. The contract has a ceiling value of $79,808.27 and is a firm fixed-price, non-set-aside delivery order with a completion date of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company, for the supply of Doxycycline Hydrochloride Injection (10). The contract has a firm fixed price of $84,622.69 and a period of performance through September 27, 2024. This contract is not set-aside and is part of a larger indefinite delivery contract (IDV) that Fresenius Kabi holds with the Department of Veterans...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned pharmaceutical company based in Lake Zurich, Illinois. The contract is for the delivery of 4553868921 Doxycycline Hydrochloride Injection (10) to support military medical facilities. The contract has a firm fixed price of $87,201.17 and a completion date of June 18, 2021. Fresenius Kabi, LLC is a significant supplier of critical care...
This federal contract award, identified as SPE2D020D0009|SPE2D324F287B, was issued by the Defense Logistics Agency (DLA) to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract is for the delivery of Doxycycline Hydrochloride Injection (10) and has a ceiling value of $53,143.79. The contract is structured as a delivery order with a firm fixed price pricing type and has an ultimate completion date of September 27, 2024. Fresenius...
This federal contract award was made by the Defense Logistics Agency Troop Support Medical to Fresenius Kabi USA, LLC, a foreign-owned, for-profit pharmaceutical company, for the delivery of doxycycline hydrochloride injection products. The $242,080.86 firm fixed price delivery order contract does not have a set-aside designation. Fresenius Kabi, which has received over $1.8 million in prior prime federal contracts, will deliver the pharmaceutical goods from its facility in Lake Zurich, Illinois...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract, valued at $85,527.80, is for the delivery of Doxycycline Hydrochloride Injection (10) to support military medical facilities worldwide. The contract is structured as a delivery order with a firm fixed price and does not have a set-aside designation. Fresenius Kabi is a...
This federal contract award, SPE2D020D0009|SPE2D321F126S, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract is for the delivery of Doxycycline Hydrochloride Injection, a critical care pharmaceutical, with a total ceiling value of $87,387.10. The contract is structured as a Firm Fixed Price Delivery Order and does not have a set-aside designation....
The U.S. Defense Logistics Agency Troop Support Medical division awarded a Firm Fixed Price Delivery Order to Fresenius Kabi, LLC, a foreign-owned for-profit pharmaceutical company, for the delivery of Doxycycline Hydrochloride Injection (10). The $173,472.69 order will be fulfilled from Fresenius Kabi's Lake Zurich, Illinois facility by June 18, 2021. Fresenius Kabi has provided a range of pharmaceutical products to DLA Troop Support Medical through prior delivery orders under blanket...
This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned for-profit pharmaceutical company. The order is for 10 units of doxycycline hydrochloride injection, with a potential value of $130,708.79 and a completion date of June 18, 2021. Fresenius Kabi is a supplier of generic injectable drugs and medical solutions to U.S. government agencies, primarily the Department of Defense (DoD) and...
This federal contract award, SPE2D020D0009|SPE2D324F286Z, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain, a defense agency, to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The $110,176.15 firm fixed-price delivery order is for the supply of Doxycycline Hydrochloride Injection (10), a critical care pharmaceutical, with a completion date of September 27, 2024. Fresenius Kabi, LLC is a major supplier of injectable...
  • SPE2D020D0009
    Indefinite Delivery Contract
  • SPE2D020D0009-SPE2D324F287J
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract is for the supply of Doxycycline Hydrochloride Injection (10), a critical care medication, with a ceiling value of $27,405.16. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of September 27, 2024. Fresenius Kabi is a major provider of generic injectable drugs, infusion therapies, and other essential medicines to the U.S. federal government, including the Department of Defense and Department of Veterans Affairs. This contract demonstrates the company's capability to consistently manufacture and supply a diverse array of critical pharmaceutical products to support military and government healthcare operations. The contract is not set aside for any specific business type.

Generated 12/24/24, 9:20 AM